Spop ameliorates diabetic nephropathy through restraining NLRP3 inflammasome.

MLA

Wang, Bin, et al. “Spop Ameliorates Diabetic Nephropathy through Restraining NLRP3 Inflammasome.” Biochemical and Biophysical Research Communications, vol. 594, Feb. 2022, pp. 131–38. EBSCOhost, https://doi.org/10.1016/j.bbrc.2021.12.068.

APA

Wang, B., Dai, Z., Gao, Q., Liu, Y., Gu, G., & Zheng, H. (2022). Spop ameliorates diabetic nephropathy through restraining NLRP3 inflammasome. Biochemical and Biophysical Research Communications, 594, 131–138. https://doi.org/10.1016/j.bbrc.2021.12.068

Chicago

Wang, Bin, Zhaohua Dai, Qian Gao, Yang Liu, Guoxiao Gu, and Huixiao Zheng. 2022. “Spop Ameliorates Diabetic Nephropathy through Restraining NLRP3 Inflammasome.” Biochemical and Biophysical Research Communications 594 (February): 131–38. doi:10.1016/j.bbrc.2021.12.068.